Amyloid fibril composition type is consistent over time in patients with Val30Met (p.Val50Met) transthyretin amyloidosis

• Intissar Anan,

  Roles Conceptualization, Funding acquisition, Investigation, Project administration, Resources, Writing – original draft, Writing – review & editing

  Affiliations Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden, Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden

  ⨯
• Ole B. Suhr,

  Roles Funding acquisition, Resources, Writing – review & editing

  Affiliation Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

  ⨯
• Katarzyna Liszewska,

  Roles Investigation, Resources

  Affiliation Department of Medicine, Piteå Hospital, Piteå, Sweden

  ⨯
• Jorge Mejia Baranda,

  Roles Investigation, Resources

  Affiliation Department of Medicine, Piteå Hospital, Piteå, Sweden

  ⨯
• Björn Pilebro,

  Roles Investigation, Resources

  Affiliation Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

  ⨯
• Jonas Wixner,

  Roles Funding acquisition, Resources, Writing – review & editing

  Affiliation Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

  ⨯
• Elisabet Ihse

  Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Project administration, Resources, Writing – original draft, Writing – review & editing

  * E-mail: elisabet.ihse@igp.uu.se

  Affiliation Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden

  https://orcid.org/0000-0001-7648-3246

  ⨯